Company Announcements

LTR Pharma’s AGM to Highlight Innovative ED Treatment

LTR Pharma Limited (AU:LTP) has released an update.

LTR Pharma Limited is set to hold its Annual General Meeting on 27 November 2024 in Brisbane, where shareholders will have the chance to discuss the company’s innovative nasal spray for Erectile Dysfunction, SPONTAN®. This product is unique due to its rapid intranasal delivery, promising quick results for users, highlighting LTR Pharma’s commitment to improving men’s health.

For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App